Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

887 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intratumoral expression levels of PD-L1, GZMA, and HLA-A along with oligoclonal T cell expansion associate with response to nivolumab in metastatic melanoma.
Inoue H, Park JH, Kiyotani K, Zewde M, Miyashita A, Jinnin M, Kiniwa Y, Okuyama R, Tanaka R, Fujisawa Y, Kato H, Morita A, Asai J, Katoh N, Yokota K, Akiyama M, Ihn H, Fukushima S, Nakamura Y. Inoue H, et al. Among authors: fujisawa y. Oncoimmunology. 2016 Jun 30;5(9):e1204507. doi: 10.1080/2162402X.2016.1204507. eCollection 2016. Oncoimmunology. 2016. PMID: 27757299 Free PMC article.
Angiosarcoma of the scalp in a patient with systemic sclerosis.
Kubota N, Fujisawa Y, Nakamura Y, Tanaka R, Saito A, Maruyama H, Ishii Y, Furutra J, Kawachi Y, Fujimoto M. Kubota N, et al. Among authors: fujisawa y. J Dermatol. 2015 Jan;42(1):102-4. doi: 10.1111/1346-8138.12705. Epub 2014 Nov 26. J Dermatol. 2015. PMID: 25425522 No abstract available.
Frequency of level II and III axillary nodes metastases in patients with positive sentinel lymph nodes in melanoma: a multi-institutional study in Japan.
Tsutsumida A, Takahashi A, Namikawa K, Yamazaki N, Uhara H, Teramoto Y, Takenouchi T, Fukushima S, Yokota K, Uehara J, Matsushita S, Shibayama Y, Hatta N, Masui Y, Uchi H, Fujisawa Y, Ogata D. Tsutsumida A, et al. Among authors: fujisawa y. Int J Clin Oncol. 2016 Aug;21(4):796-800. doi: 10.1007/s10147-015-0944-y. Epub 2016 Jan 13. Int J Clin Oncol. 2016. PMID: 26759315
Nivolumab-induced thyroid dysfunction.
Tanaka R, Fujisawa Y, Maruyama H, Nakamura Y, Yoshino K, Ohtsuka M, Fujimoto M. Tanaka R, et al. Among authors: fujisawa y. Jpn J Clin Oncol. 2016 Jun;46(6):575-9. doi: 10.1093/jjco/hyw036. Epub 2016 Mar 23. Jpn J Clin Oncol. 2016. PMID: 27012985
Serum level of interleukin-6 is increased in nivolumab-associated psoriasiform dermatitis and tumor necrosis factor-α is a biomarker of nivolumab recativity.
Tanaka R, Okiyama N, Okune M, Ishitsuka Y, Watanabe R, Furuta J, Ohtsuka M, Otsuka A, Maruyama H, Fujisawa Y, Fujimoto M. Tanaka R, et al. Among authors: fujisawa y. J Dermatol Sci. 2017 Apr;86(1):71-73. doi: 10.1016/j.jdermsci.2016.12.019. Epub 2016 Dec 29. J Dermatol Sci. 2017. PMID: 28069323 No abstract available.
887 results